Cellectis - ADRCLLS
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 27 institutions reported holding Cellectis - ADR (CLLS) in their 13F filings, down 3 from Q1 2024. 4 opened new positions and 6 sold out. The largest holders were Long Focus Capital Management, LLC ($8.6M), Capital International Investors ($3.5M) and UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ($2.7M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cellectis - ADR
- CUSIP
- 15117K103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $2.8M |
| Exits | 6 | $436K |
All 13F filers, Q1 2024 → Q2 2024: 1,650,451 shares bought and 294,171 shares sold, net +1,356,280 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Long Focus Capital Management, LLC | 0.89% | Add +2.9% | 4,617,293 | $8.6M |
| Capital International Investors | 0.00% | No change | 1,848,804 | $3.5M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | New | 1,438,255 | $2.7M |
| Baillie Gifford & Co. | 0.00% | Reduce -14.5% | 707,630 | $1.3M |
| Principal Financial Group Inc. | 0.00% | Add +2.9% | 437,000 | $817K |
| Macquarie Group Ltd. | 0.00% | No change | 226,875 | $424K |
| KBC Group NV | 0.00% | No change | 163,447 | $306K |
| LPL Financial LLC | 0.00% | Add +12.8% | 91,787 | $172K |
| Morgan Stanley | 0.00% | Add +2.6% | 86,325 | $161K |
| Two Sigma Investments, LP | 0.00% | Reduce -19.2% | 40,289 | $75K |
| Citadel Advisors | 0.00% | New | 26,699 | $50K |
| BNP Paribas Financial Markets | 0.00% | Reduce -0.6% | 16,700 | $31K |
| XTX Topco Ltd | 0.00% | New | 15,320 | $29K |
| Baird Financial Group, Inc. | 0.00% | New | 15,090 | $28K |
| Wells Fargo & Company | 0.00% | Reduce -1.2% | 12,790 | $24K |
| Geode Capital Management, LLC | 0.00% | No change | 10,776 | $20K |
| Harbour Investments, Inc. | 0.00% | No change | 6,100 | $11K |
| Rhumbline Advisers | 0.00% | No change | 3,855 | $7K |
| National Bank of Canada | 0.00% | No change | 3,600 | $7K |
| BlackRock Inc. | 0.00% | No change | 2,755 | $5K |
| Allworth Financial LP | 0.00% | No change | 500 | $1K |
| POM Investment Strategies, LLC | 0.00% | No change | 495 | $926 |
| Qube Research & Technologies Ltd | 0.00% | Reduce -64.1% | 112 | $210 |
| JPMorgan Chase & Co. | 0.00% | No change | 83 | $155 |
| Toronto Dominion Bank | 0.00% | No change | 31 | $58 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 13 | $29 |
| Bank of America Corp. | 0.00% | Reduce -94.4% | 2 | $4 |
"% of holder's portfolio" is CLLS's weight in each manager's 13F, not the share of Cellectis - ADR the manager owns.